Dose-Volume Parameters of MRI Active Bone Marrow Versus Total Bone Marrow As Predictor of Hematologic Toxicity in Rectal Cancer Patients during Neoadjuvant Chemoradiation Therapy

Kuncman L.; Maslowski M.; Danielska J.; Luniewska-Bury J.; Fijuth J.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Dose-Volume Parameters of MRI Active Bone Marrow Versus Total Bone Marrow As Predictor of Hematologic Toxicity in Rectal Cancer Patients during Neoadjuvant Chemoradiation Therapy

【24h】

Dose-Volume Parameters of MRI Active Bone Marrow Versus Total Bone Marrow As Predictor of Hematologic Toxicity in Rectal Cancer Patients during Neoadjuvant Chemoradiation Therapy

机译：MRI活性骨髓与总骨髓的剂量参数，作为Neoadjuvant Chemoradiation疗法直肠癌患者血液学毒性预测因子

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2017年第2suppla期|共1页
作者
Kuncman L.; Maslowski M.; Danielska J.; Luniewska-Bury J.; Fijuth J.;
展开▼
作者单位

Med Univ Lodz Dept Radiotherapy Lodz Poland;

Copernicus Mem Hosp Lodz Reg Canc Ctr Dept Teleradiotherapy Lodz Poland;

Med Univ Lodz Dept Radiotherapy Lodz Poland;

Copernicus Mem Hosp Lodz Reg Canc Ctr Dept Brachytherapy Lodz Poland;

Med Univ Lodz Dept Radiotherapy Lodz Poland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Dose-Volume Parameters of MRI Active Bone Marrow Versus Total Bone Marrow As Predictor of Hematologic Toxicity in Rectal Cancer Patients during Neoadjuvant Chemoradiation Therapy [J] . Kuncman L., Maslowski M., Danielska J., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：MRI活性骨髓与总骨髓的剂量参数，作为Neoadjuvant Chemoradiation疗法直肠癌患者血液学毒性预测因子
2. Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Locally Advanced Rectal Cancer Patients Treated with Concurrent Weekly Irinotecan in Combination with Capecitabine-Based Chemoradiotherapy and Neoadjuvant IMRT [J] . Zhang J., Wan J., Wang J., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：含有每周晚期氨基替康的局部晚期直肠癌患者骨髓剂量和急性血液学毒性与Capecitabine的化学疗法和Neoadjuvant联合治疗
3. The Volume of PET-Defined, Active Bone Marrow Spared Predicts Acute Hematologic Toxicities in Anal Cancer Patients Receiving Concurrent Chemoradiation Therapy [J] . Freese C., Sudhoff M., Lewis L. M., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：宠物定义的活性骨髓备受级别的体积预测接受同时析疗疗法的肛门癌患者中的急性血液学毒性
4. Texture kinetic features from pre-treatment DCE MRI for predicting pathologic tumor stage regression after neoadjuvant chemoradiation in rectal cancers [C] . Siddhartha Nanda, Jacob T. Antunes, Kaustav Bera, Conference on Medical Imaging: Image-Guided Procedures, Robotic Interventions, and Modeling . 2020

机译：预处理DCE MRI的纹理动力学特征可预测直肠癌新辅助化学放疗后病理性肿瘤分期
5. Analysis of Single Nucleotide Polymorphisms (SNPs) and Dose-volume Parameters on Predicting for Rectal Toxicity, Erectile Dysfunction, and Urinary Morbidity Following Treatment for Prostate Cancer Using Radiotherapy. [D] . Taneja, Sameer. 2014

机译：分析单核苷酸多态性（SNP）和剂量参数对使用放射疗法治疗前列腺癌后的直肠毒性，勃起功能障碍和尿毒症的预测。
6. Association between dose-volume parameters and acute bone marrow suppression in rectal cancer patients treated with concurrent chemoradiotherapy [O] . Nan Li, Xue Liu, Fushan Zhai, 2017

机译：同步放化疗治疗的直肠癌患者剂量参数与急性骨髓抑制的关系
7. Dose-Volume Parameters of MRI Active Bone Marrow Versus Total Bone Marrow As Predictor of Hematologic Toxicity in Rectal Cancer Patients during Neoadjuvant Chemoradiation Therapy [O] . L. Kuncman, M. Maslowski, J. Danielska, 2017

机译：MRI活性骨髓与总骨髓的剂量参数，作为Neoadjuvant Chemoradiation疗法直肠癌患者血液学毒性预测因子

Dose-Volume Parameters of MRI Active Bone Marrow Versus Total Bone Marrow As Predictor of Hematologic Toxicity in Rectal Cancer Patients during Neoadjuvant Chemoradiation Therapy

著录项

相似文献

相关主题

期刊订阅